Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis.

Moore JE, Koulianos G, Hardy M, Misawa N, Millar BC.

Int J Mycobacteriol. 2018 Jul-Sep;7(3):265-267. doi: 10.4103/ijmy.ijmy_73_18.

PMID:
30198508
2.

Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for Mycobacterium abscessus and cystic fibrosis.

Moore RE, Millar BC, Panickar JR, Moore JE.

Int J Mycobacteriol. 2018 Jul-Sep;7(3):257-260. doi: 10.4103/ijmy.ijmy_72_18.

PMID:
30198506
3.

Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.

Millar BC, Rendall JC, Downey DG, Moore JE.

J Clin Pharm Ther. 2018 Jun 29. doi: 10.1111/jcpt.12722. [Epub ahead of print]

PMID:
29959786
4.

Antimicrobial effect of dimethyl sulfoxide and N, N-Dimethylformamide on Mycobacterium abscessus: Implications for antimicrobial susceptibility testing.

Kirkwood ZI, Millar BC, Downey DG, Moore JE.

Int J Mycobacteriol. 2018 Apr-Jun;7(2):134-136. doi: 10.4103/ijmy.ijmy_35_18.

5.

"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Gilligan PH, Downey DG, Elborn JS, Flume PA, Funk S, Gilpin D, Kidd TJ, McCaughan J, Millar BC, Murphy PG, Rendall JC, Tunney MM, Moore JE.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00193-18. doi: 10.1128/JCM.00193-18. Print 2018 Sep.

PMID:
29875191
6.

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW.

Gramegna A, Moore JE, McCaughan J, Millar BC, Ewing J, Elborn JS, Blasi F, Downey DG.

Ulster Med J. 2018 May;87(2):129-130. Epub 2018 May 30. No abstract available.

7.

Meningococcal Disease in Northern Ireland - Past, Present & Future: MeningoNI Forum.

Millar BC, Banks L, Bourke TW, Cunningham M, Dooley J, Elshibly S, Goldsmith CE, Fairley D, Jackson K, Lamont S, Jessop L, McCrudden E, McConnell D, McAuley K, McKenna JP, Moore P, Smithson R, Stirling J, Shields M, Moore JE.

Ulster Med J. 2018 May;87(2):83. Epub 2018 May 30. Review.

8.

In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.

Gramegna A, Millar BC, Blasi F, Elborn JS, Downey DG, Moore JE.

J Glob Antimicrob Resist. 2018 Sep;14:224-227. doi: 10.1016/j.jgar.2018.03.002. Epub 2018 Mar 17.

PMID:
29559421
9.

Muddy puddles - the microbiology of puddles located outside tertiary university teaching hospitals.

Furukawa M, McCaughan J, Stirling J, Millar BC, Bell J, Goldsmith CE, Reid A, Misawa N, Moore JE.

Lett Appl Microbiol. 2018 Apr;66(4):284-292. doi: 10.1111/lam.12856. Epub 2018 Feb 23.

PMID:
29377174
10.

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

Millar BC, McCaughan J, Rendall JC, Downey DG, Moore JE.

J Clin Pharm Ther. 2018 Feb;43(1):92-100. doi: 10.1111/jcpt.12616. Epub 2017 Sep 22.

PMID:
29293275
11.

Meningococcal ACWY vaccine uptake and awareness among student freshers enrolled at Northern Ireland universities.

Moore PJ, Millar BC, Moore JE.

Int J Adolesc Med Health. 2017 Jan 18. pii: /j/ijamh.ahead-of-print/ijamh-2016-0087/ijamh-2016-0087.xml. doi: 10.1515/ijamh-2016-0087. [Epub ahead of print]

PMID:
28099125
12.

Meningococcal disease: has the battle been won?

Millar BC, Moore PJA, Moore JE.

J R Army Med Corps. 2017 Aug;163(4):235-241. doi: 10.1136/jramc-2016-000695. Epub 2016 Dec 30. Review.

PMID:
28039342
13.

Viability of meticillin-resistant Staphylococcus aureus after long-term storage on Dorset egg medium.

Sudo K, Elshibly M, Stirling J, Goldsmith CE, Millar BC, Misawa N, Moore JE.

J Med Microbiol. 2016 Dec;65(12):1540-1541. doi: 10.1099/jmm.0.000364. Epub 2016 Oct 14. No abstract available.

PMID:
27902369
14.

Automated teller machines (ATMs) and pedestrian crossing controls adjacent to major university teaching hospitals exhibit an exclusively Gram-positive flora.

Elshibly M, Sudo K, Stirling J, Millar BC, Misawa N, Goldsmith CE, Moore JE.

J Hosp Infect. 2016 Dec;94(4):400-401. doi: 10.1016/j.jhin.2016.09.014. Epub 2016 Sep 23. No abstract available.

PMID:
27756488
15.

Molecular identification and characterisation of catalase and catalase-like protein genes in urease-positive thermophilic Campylobacter (UPTC).

Nakajima T, Kuribayashi T, Moore JE, Millar BC, Yamamoto S, Matsuda M.

Br J Biomed Sci. 2016;73(2):56-66. doi: 10.1080/09674845.2016.1156867. Epub 2016 Apr 29.

PMID:
27181172
16.

New diagnostic approaches in infective endocarditis.

Millar BC, Habib G, Moore JE.

Heart. 2016 May 15;102(10):796-807. doi: 10.1136/heartjnl-2014-307021. Epub 2016 Feb 23. Review. No abstract available.

PMID:
26908095
17.

Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters.

Shteinberg M, Kis-Papo T, Millar BC, Rendall JC, Downey DG, Elborn JS, Moore JE.

J Water Health. 2015 Sep;13(3):773-6. doi: 10.2166/wh.2015.157.

PMID:
26322762
18.

Transformation and characterization of an arsenic gene operon from urease-positive thermophilic Campylobacter (UPTC) in Escherichia coli.

Matsuda M, Kuribayashi T, Yamamoto S, Millar BC, Moore JE.

Folia Microbiol (Praha). 2016 Jan;61(1):57-62. doi: 10.1007/s12223-015-0405-z. Epub 2015 Jun 30.

PMID:
26122364
19.

Molecular analysis of the tlyA gene in Campylobacter lari.

Matsubara K, Nakajima T, Moore JE, Millar BC, Murayama T, Matsuda M.

Folia Microbiol (Praha). 2015 Nov;60(6):505-14. doi: 10.1007/s12223-015-0389-8. Epub 2015 Apr 24.

PMID:
25906999
20.

Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?

Moore JE, Alcorn M, Ara W, Millar BC, McCaughan J, Rendall JC, McNeilly J, Kuribayashi T, Yamamoto S, Matsuda M, Goldsmith CE, Elborn JS, Downey DG.

Int J Antimicrob Agents. 2015 Jan;45(1):93-5. doi: 10.1016/j.ijantimicag.2014.08.003. Epub 2014 Sep 6. No abstract available.

PMID:
25245210
21.

High diversity of bacterial pathogens and antibiotic resistance in salmonid fish farm pond water as determined by molecular identification employing 16S rDNA PCR, gene sequencing and total antibiotic susceptibility techniques.

Moore JE, Huang J, Yu P, Ma C, Moore PJ, Millar BC, Goldsmith CE, Xu J.

Ecotoxicol Environ Saf. 2014 Oct;108:281-6. doi: 10.1016/j.ecoenv.2014.05.022. Epub 2014 Aug 6.

PMID:
25105488
22.

Detection of the prodigiosin biosynthesis protein (pigC) from Serratia marcescens: development of a novel PCR assay.

Tasaki E, Nakajima T, Millar BC, Goldsmith CE, Coulter WA, Matsuda M, Elborn JS, Moore JE.

Br J Biomed Sci. 2014;71(2):82-3. No abstract available.

PMID:
24974684
23.

Molecular characterisation of a type III restriction-modification system in Campylobacter upsaliensis.

Nakajima T, Ono K, Tazumi A, Misawa N, Moore JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2014;71(2):66-72.

PMID:
24974681
24.

Construction and expression of a recombinant urease gene cluster from Campylobacter sputorum biovar paraureolyticus.

Nakajima T, Kuribayashi T, Yamamoto S, Moore JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2014;71(2):58-65.

PMID:
24974680
25.

Reliability of self-reporting of antibiotic consumption in the community - Index of Reliability.

Ferson K, Montgomery J, Moore RE, Millar BC, Leggett P, Coulter WA, Goldsmith CE, Moore JE.

J Clin Pharm Ther. 2014 Oct;39(5):468-70. doi: 10.1111/jcpt.12184. Epub 2014 Jun 9.

PMID:
24912052
26.

Molecular structural analysis of major outer membrane protein (MOMP) gene clusters in Campylobacter lari.

Nakajima T, Ara W, Saito K, Moores JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2014;71(1):19-28.

PMID:
24693571
27.

Effective oral health in infective endocarditis: efficacy of high-street mouthwashes against the viridans group streptococci.

Elshibly A, Coulter WA, Millar BC, Prendergast BD, Thornhill M, Irwin C, Goldsmith CE, Moore JE.

J Investig Clin Dent. 2014 May;5(2):151-3. doi: 10.1111/jicd.12088. Epub 2014 Mar 7.

PMID:
24610586
28.

Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.

Nakajima T, Nakanishi S, Mason C, Montgomery J, Leggett P, Matsuda M, Coulter WA, Millar BC, Goldsmith CE, Moore JE.

Ulster Med J. 2013 Sep;82(3):164-8.

29.

Increased susceptibility to antibiotics in gram-negative and gram-positive pathogens, including Pseudomonas aeruginosa, at lower temperature: is antibiotic resistance reversal possible?

Moore JE, Moore RJ, Downey D, Millar BC, Coulter WA, Goldsmith CE.

Br J Biomed Sci. 2013;70(4):173-4. No abstract available.

PMID:
24400429
30.

Construction, expression and characterisation of recombinant molecules of the urease gene operon from a urease-positive thermophilic Campylobacter (UPTC) isolate.

Nakanishi S, Nakajima T, Tazumi A, Matsubara K, Moore JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2013;70(1):15-21.

PMID:
23617093
31.

18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection.

Millar BC, Prendergast BD, Alavi A, Moore JE.

Int J Cardiol. 2013 Sep 1;167(5):1724-36. doi: 10.1016/j.ijcard.2012.12.005. Epub 2013 Jan 11. Review.

PMID:
23313465
32.

Examination of the antibacterial properties of sphagnum moss (Sphagnum spp.) and its significance with turf burning in Ireland.

Moore RJ, Rao JR, Nelson D, McCollum G, Ballard LM, Millar BC, Nakanishi S, Tasaki E, Nakajima T, Matsuda M, Goldsmith CE, Coulter WA, Loughrey A, Rooney RJ, O'Sullivan JT, Moore JE.

Br J Biomed Sci. 2012;69(4):178-80. No abstract available.

PMID:
23304795
33.

Molecular identification of an arsenic four-gene operon in Campylobacter lari.

Nakajima T, Hayashi K, Nagatomi R, Matsubara K, Moore JE, Millar BC, Matsuda M.

Folia Microbiol (Praha). 2013 May;58(3):253-60. doi: 10.1007/s12223-012-0207-5. Epub 2012 Nov 7.

PMID:
23132657
34.

Isolation and identification of 'Mycobacterium angelicum' from a patient with type II respiratory failure: suggested reporting guidelines to molecular clinical laboratories.

Davies E, Wieboldt J, Stanley T, Maeda Y, Smyth M, Stanley S, McClean M, Evans W, Funston C, Millar BC, Goldsmith CE, Moore JE.

Br J Biomed Sci. 2012;69(3):134-6. No abstract available.

PMID:
23057162
35.

Exposure to clinical X-ray radiation does not alter antibiotic susceptibility or genotype profile in gram-negative and gram-positive clinical pathogens.

Hayashi K, Hirayama J, Goldsmith CE, Coulter WA, Millar BC, Dooley JS, Loughrey A, Rooney PJ, Matsuda M, Moore JE.

Br J Biomed Sci. 2012;69(3):119-22.

PMID:
23057159
36.

Mining the antibiogram: what more can it tell us?

Moore JE, Millar BC, Coulter WA, Mason C, Rooney RJ, Loughrey A, Goldsmith CE.

Br J Biomed Sci. 2012;69(2):76-80. No abstract available.

PMID:
22872932
37.

Molecular identification and characterization of clustered regularly interspaced short palindromic repeats (CRISPRs) in a urease-positive thermophilic Campylobacter sp. (UPTC).

Tasaki E, Hirayama J, Tazumi A, Hayashi K, Hara Y, Ueno H, Moore JE, Millar BC, Matsuda M.

World J Microbiol Biotechnol. 2012 Feb;28(2):713-20. doi: 10.1007/s11274-011-0867-3. Epub 2011 Aug 28.

PMID:
22806867
38.

Molecular analysis of the 16S-23S rDNA internal spacer region (ISR) and truncated tRNA(Ala) gene segments in Campylobacter lari.

Hayashi K, Tazumi A, Nakanishi S, Nakajima T, Matsubara K, Ueno H, Moore JE, Millar BC, Matsuda M.

World J Microbiol Biotechnol. 2012 Jun;28(6):2403-10. doi: 10.1007/s11274-012-1049-7. Epub 2012 Apr 10.

PMID:
22806114
39.

UVc-irradiation sublethal stress does not alter antibiotic susceptibility of staphylococci (MRSA, MSSA, and coagulase-negative staphylococci) to β-lactam, macrolide, and fluoroquinolone antibiotic agents.

Maeda Y, Goldsmith CE, Coulter WA, Millar BC, Dooley JS, Lowery CJ, Loughrey A, Rooney PJ, McDowell DA, Matsuda M, Moore JE.

J Cosmet Sci. 2012 Mar-Apr;63(2):133-7.

PMID:
22591564
40.

Polymerase chain reaction amplification: effect of dyes and other staining agents employed in clinical microbiology laboratories.

Hirayama J, Hayashi K, Goldsmith CE, Coulter WA, Millar BC, Dooley JS, Matsuda M, Moore JE.

Br J Biomed Sci. 2012;69(1):35-7. No abstract available.

PMID:
22558804
41.

Expression and analysis of a cytolethal distending toxin (cdt) gene operon in Campylobacter lari.

Nakajima T, Tazumi A, Hirayama J, Hayashi K, Tasaki E, Asakura M, Yamasaki S, Moored JE, Millar BC, Matsubarak K, Matsuda M.

Br J Biomed Sci. 2012;69(1):26-30.

PMID:
22558801
42.

Antibacterial effects on acinetobacter species of commonly employed antineoplastic agents used in the treatment of haematological malignancies: an in vitro laboratory evaluation.

McCarron AJ, Armstrong C, Glynn G, Millar BC, Rooney PJ, Goldsmith CE, Xu J, Moore JE.

Br J Biomed Sci. 2012;69(1):14-7.

PMID:
22558799
43.

Biochemical characterisation of urease from urease-positive thermophilic campylobacter (UPTC).

Tazumi A, Nakajima T, Sekizuka A, Arikawa K, Nakanishi S, Hayashi K, Tasaki E, Moore JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2012;69(1):1-5.

PMID:
22558796
44.

Comparative analysis of Campylobacter lari cytolethal distending toxin (CDT) effect on HeLa cells.

Nakajima T, Hirayama J, Tazumi A, Hayashi K, Tasaki E, Asakura M, Yamasaki S, Moore JE, Millar BC, Matsuda M.

J Basic Microbiol. 2012 Oct;52(5):559-65. doi: 10.1002/jobm.201100297. Epub 2012 Feb 23.

PMID:
22359318
45.

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.

Rao P, McCaughan J, McCalmont M, Goldsmith CE, Hall V, Millar BC, McCann MA, Downey DG, Rendall JC, Elborn JS, Moore JE.

J Cyst Fibros. 2012 Jul;11(4):349-52. doi: 10.1016/j.jcf.2012.01.002. Epub 2012 Feb 9. No abstract available.

46.

Comparasion of five gene loci (rnpB, 16S rRNA, 16S-23S rRNA, sodA and dnaJ) to aid the molecular identification of viridans-group streptococci and pneumococci.

Maeda Y, Goldsmith CE, Coulter WA, Mason C, Dooley JS, Lowery CJ, Millar BC, Moore JE.

Br J Biomed Sci. 2011;68(4):190-6.

PMID:
22263433
47.

Reliability of a multiplex PCR assay for the identification of the major Campylobacter taxa.

Hayashi K, Tazumi A, Nakajima T, Endo A, Moore JE, Millar BC, Matsuda M.

Br J Biomed Sci. 2011;68(4):185-9.

PMID:
22263432
48.

Molecular characterisation of the quinolone resistance-determining region (QRDR) of the parC gene locus in viridans-group streptococci.

Murayama M, Maeda Y, Goldsmith CE, Coulter WA, Masons C, Millar BC, Matsuda M, Moore JE.

Br J Biomed Sci. 2011;68(3):109-11.

PMID:
21950200
49.

Exposure to sublethal clinical radiotherapeutic doses of ionizing γ-radiation gives rise to mutants of Gram-negative and Gram-positive clinical pathogens with increased antibiotic resistance.

Moore PJ, Goldsmith CE, Coulter WA, Millar BC, Matsuda M, Moore JE.

J Med Microbiol. 2012 Feb;61(Pt 2):302-4. doi: 10.1099/jmm.0.035279-0. Epub 2011 Sep 22. No abstract available.

PMID:
21940648
50.

Phylogenetic analysis of urease-positive thermophilic Campylobacter (UPTC) strains based on the molecular characterization of the flaA gene.

Murayama M, Tazumi A, Hayashi K, Nakanishi S, Tasaki E, Ueno H, Nakajima T, Matsubara K, Moore JE, Millar BC, Matsuda M.

Folia Microbiol (Praha). 2011 Sep;56(5):397-406. doi: 10.1007/s12223-011-0061-x. Epub 2011 Aug 28.

PMID:
21874596

Supplemental Content

Loading ...
Support Center